Baidu
map

Biomed Pharmacother:当心!你的容颜易逝可能是慢性高血糖惹的祸

2019-01-12 国际糖尿病编辑部 国际糖尿病

从某种意义上讲,慢性高糖是一个让你的身体慢慢“生锈”的过程。容颜老化不过是这种“生锈”发展到一定程度之后的外在表现,事实上体内的进展或许更加令人担忧。预防铁器的生锈需要控制湿度,而预防体内的“生锈”,你需要控制好你的糖。

经过多年的科普,很多人都很清楚血糖控制不好往往需要付出代价,并且第一时间脑子里可以闪现出肥胖、血管疾病、卒中糖尿病视网膜病变、糖尿病肾病、糖尿病足……等等。然而有一种代价,或许是因为近年来的研究才慢慢浮出水面,多数人可能完全没有想到过,并且这些人若恰恰又是天生爱美的女性的话,估计好好了解一番之后今晚后半夜都要睡不好了。但就算今夜无眠、也依然有必要了解。否则不仅风险依然存在、而且可能由于不知情而令后果更加严重。

爱美的你一定注意到了,很多美容护肤产品都少不了提到一个词“抗氧化”。抗氧化是否真的能够年轻或者看上去更年轻呢?至少现代科学给出我们这样的解释:氧化应激(Oxidative Stress,OS)是指体内氧化与抗氧化作用失衡,倾向于氧化,导致中性粒细胞炎性浸润,蛋白酶分泌增加,产生大量氧化中间产物。OS是由自由基在体内产生的一种负面作用,并被认为是导致衰老和疾病的一个重要因素。所以为肌肤抗氧化,理论上的确是在助力对抗岁月留下的痕迹。

这与糖尿病有什么关系呢

氧化应激在糖尿病的发生和发展中起着至关重要的作用。糖酵解、己糖胺、蛋白激酶C(PKC)、多元醇和糖基化终末产物(AGE)等不同代谢途径中的多个分子事件级联被认为是促氧化过程,通常在糖尿病患者中上调。这绝对不是危言耸听。最近发表在Biomedicine & Pharmacotherapy杂志上的一篇文章,为我们很好地阐述了糖尿病患者氧化应激相关的分子机制。

葡萄糖在人体细胞中被氧化是非常重要的。发生这种情况的最初过程称为糖酵解。它是一个十步酶催化途径,会产生自由基。在正常生理条件下,这些自由基是可以被机体抗氧化防御网络应付的。然而,在高血糖的情况下,会产生过量的超氧阴离子自由基(O2-),抑制机体抗氧化系统诱导氧化应激,对核DNA及其他生物分子造成损伤。随后激活DNA修复酶(多聚ADP核糖聚合酶1)。该酶抑制甘油醛-3-磷酸脱氢酶的活性,导致甘油醛-3-磷酸的积累,而这一过程又激活一系列的促氧化过程,包括己糖胺、多元醇、蛋白激酶和晚期糖基化终产物(AGEs)途径(图1)。



图1. 高血糖状态下的葡萄糖氧化和诱导氧化应激

葡萄糖在血液中的积累可导致分子的自氧化,从而形成AGEs前体。同样,葡萄糖分解代谢产物也产生AGEs前体。这些AGEs均可与不同年龄的受体结合或与生物分子相互作用,通过蛋白激酶C(PKC)的活化直接或间接引发OS(图2)。AGEs,特别是修饰蛋白,同时存在于细胞内和细胞外基质中。当细胞内和细胞外的蛋白质与AGEs氨基酸组成基团,尤其是与肌肤中的胶原蛋白紧密结合就会导致肌肤失去弹性,继而诱发一系列令爱美人士极其焦虑的肌肤状况:皱纹增加、暗斑、松弛、干燥、粗糙等,总有一款找上你。



图2. AGEs的形成和高血糖诱导的氧化应激

PKC是一种通过级联反应磷酸化过程来调节其他蛋白活性的蛋白质。该酶是细胞信号通路的关键元素。氧化应激诱导DNA损伤激活的多聚ADP核糖聚合酶1抑制一些酶使得体内在高糖环境下产生甘油-3-磷酸,甘油-3-磷酸在游离脂肪酸存在下形成二酰基甘油,与AGEs受体相互作用,通过PKC活化诱导氧化应激(图3)。



图3. 高血糖中PKC的活化和诱导的氧化应激

在高血糖细胞条件下,糖酵解还会触发己糖胺通路在糖尿病中的毒性和促氧化作用(图4)。



图4. 高血糖引起的己糖胺通路的过度活跃

此外,在高血糖水平下,醛糖还原酶被激活,导致山梨醇水平升高,山梨醇脱氢酶转化为果糖。高水平的果糖导致磷酸甘油醛(GAP)和二羟丙酮二磷酸(DHAP)的积累,通过甲基乙二醇的形成和PKC的活化导致氧化应激。此外,醛糖还原酶活性的增加导致NADPH水平显著下降,进而导致谷胱甘肽过氧化物酶活性和谷胱甘肽水平下降。这种情况导致抗氧化防御网格的抑制,进而加速氧化应激(图5)。



图5. 高血糖引起的多酚通路的过度活跃

最后,高血糖诱导的氧化应激还可促使胰岛素信号通路失活。

由于氧化应激在糖尿病和糖尿病并发症中的重要作用,抗氧化剂的摄入显然并不能预防糖尿病,那么对于现阶段的糖尿病患者来讲,控制好血糖无疑就是预防衰老、预防并发症的良方。

结语

从某种意义上讲,慢性高糖是一个让你的身体慢慢“生锈”的过程。容颜老化不过是这种“生锈”发展到一定程度之后的外在表现,事实上体内的进展或许更加令人担忧。预防铁器的生锈需要控制湿度,而预防体内的“生锈”,你需要控制好你的糖。

原始出处:
Osasenaga MacdonaldIghodaro, et al. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomedicine & Pharmacotherapy, 2018 Dec.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
    2019-08-16 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
    2019-10-08 yb6560
  4. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
    2019-11-24 jj000001
  5. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
    2019-01-14 hbwxf
  6. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1918477, encodeId=28dc19184e7ea, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Aug 16 22:19:00 CST 2019, time=2019-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Oct 10 10:19:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996262, encodeId=d754199626252, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Tue Oct 08 03:19:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787573, encodeId=798a1e87573a4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Nov 24 05:19:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261170, encodeId=20ed12611e0b5, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609488, encodeId=ce7f1609488da, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jan 14 10:19:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358064, encodeId=6fb635806478, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/13/41188667d97bcca853e40abd86f6b228.jpg, createdBy=7c862525994, createdName=Nancy7994, createdTime=Mon Jan 14 00:19:19 CST 2019, time=2019-01-14, status=1, ipAttribution=)]
    2019-01-14 Nancy7994

    学习了

    0

相关资讯

J Funct Foods:熟蕃茄酱,能促进肠道健康?

蕃茄酱能促进肠道健康?如果是的话,应该选择生的还是熟的?

AGING CELL:抗氧化改善唐氏综合征早衰症状

越来越多的证据表明慢性氧化应激是衰老过程的关键驱动因素。唐氏综合症(DS)的特征在于复杂的表型,包括早衰。

Microb Pathog:成熟果实提取物可有效抗氧化及抗菌

本研究旨在利用气相色谱-质谱联用技术鉴定S. ripe草成熟果实的精油(EO),丙酮提取物(ACE)和正己烷提取物(HexE)的化学成分和生物活性。分别使用Folin-Ciocalteu和1,1-二苯基-2-苦基肼基(DPPH)测定法测定总酚含量和提取物的抗氧化活性。使用盘扩散法在125和2000μg/mL浓度之间测量抑制区(IZs)来测定对鲍曼不动杆菌、枯草芽孢杆菌、大肠杆菌、黄色微球菌、铜绿假

PLos Biol:睡眠的重要作用——抗氧化!

百年三万六千日,几乎生命中三分之一的时间我们都在睡觉。但在现代社会,长期睡眠缺乏已经成为普遍现象,深入理解睡眠变得越来越重要,因为很多证据表明睡眠剥夺和负面健康影响之间存在相关性。然而,睡眠的核心功能对我们来说仍然是个谜。根据7月12日发表在《PLOS Biology》上的一项新研究,哥伦比亚大学的Vanessa Hill和Mimi Shirasu-Hiza发现,睡眠缺乏的果蝇突变体在对急性氧化应

BMC Complement Altern Med:印楝提取物或可用于牙周病的治疗

印度楝树制备的咀嚼棒或可用于牙周疾病的治疗。本研究旨在探讨印楝叶提取物对牙龈卟啉单胞菌和牙髓有丝分裂菌的抗菌作用及其抗氧化能力,以及与可能在炎症部位的细菌和聚阳离子肽的结合。 通过乙醇提取制备印楝叶提取物。厌氧环境中,在Neem叶提取物存在下评估P.gingivalis和F. nucleatum的生长。肉汤微量稀释试验用于确定印楝叶提取物对每种细菌菌株的最小抑制浓度(MIC)。通过视觉半定量

AGING CELL:抗氧化蛋白过度活化竟会加速老化

后生动物的生存能力取决于它们调节代谢过程的能力,也可以通过增加抗应激反应来应对有害的挑战。

Baidu
map
Baidu
map
Baidu
map